Acer Therapeutics’ $2.675 Million Registered Direct Offering

Martina Bellini North America Legal Chronicle
Tagged:

Pillsbury advised Acer Therapeutics on the deal.Acer Therapeutics, a leading pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here